Cargando…

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Wambier, Carlos Gustavo, Vaño-Galván, Sergio, McCoy, John, Gomez-Zubiaur, Alba, Herrera, Sabina, Hermosa-Gelbard, Ángela, Moreno-Arrones, Oscar M., Jiménez-Gómez, Natalia, González-Cantero, Alvaro, Fonda-Pascual, Pablo, Segurado-Miravalles, Gonzalo, Shapiro, Jerry, Pérez-García, Bibiana, Goren, Andy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242206/ https://www.ncbi.nlm.nih.gov/pubmed/32446821 http://dx.doi.org/10.1016/j.jaad.2020.05.079

Ejemplares similares

Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Reply to comment on: The Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2021)

Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
por: Goren, Andy, et al.
Publicado: (2021)

Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Comment on: The Gabrin sign
por: Trüeb, Ralph M., et al.
Publicado: (2021)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia
por: Gomez-Zubiaur, Alba, et al.
Publicado: (2023)

Alopecia Areata Sisaipho: Clinical and Therapeutic Approach in 13 Patients in Spain
por: Fonda-Pascual, Pablo, et al.
Publicado: (2016)

Androgenetic alopecia: An update
por: Ntshingila, Sincengile, et al.
Publicado: (2023)

Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Cadegiani, Flavio A, et al.
Publicado: (2021)

Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia
por: Ragi, Sara D., et al.
Publicado: (2023)

Characteristics of Androgenetic Alopecia in Asian
por: Lee, Won-Soo, et al.
Publicado: (2012)

Oxidative stress in androgenetic alopecia
por: Prie, BE, et al.
Publicado: (2016)

Trichoscopic Findings in Androgenetic Alopecia
por: Kasumagic-Halilovic, Emina
Publicado: (2021)

Androgenetic Alopecia: Therapy Update
por: Devjani, Shivali, et al.
Publicado: (2023)

Topical Melatonin for Treatment of Androgenetic Alopecia
por: Fischer, Tobias W, et al.
Publicado: (2012)

Role of Caffeine in the Management of Androgenetic Alopecia
por: Bansal, Manish, et al.
Publicado: (2012)

Involvement of Mechanical Stress in Androgenetic Alopecia
por: Tellez-Segura, Rafael
Publicado: (2015)

Platelet-Rich Plasma in Androgenetic Alopecia
por: Sharma, Aseem, et al.
Publicado: (2021)

Regenerative Medicine Treatments for Androgenetic Alopecia
por: Mysore, Venkataram, et al.
Publicado: (2021)

Adipose transcriptome in the scalp of androgenetic alopecia
por: Cruz, Criselda Jean G., et al.
Publicado: (2023)

Combination and Rotational Therapy in Androgenetic Alopecia
por: Mysore, Venkatram, et al.
Publicado: (2023)

Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
por: Gonul, Muzeyyen, et al.
Publicado: (2018)

An anti‐hair loss treatment in the management of mild androgenetic alopecia: Results from a large, international observational study
por: Reygagne, Pascal, et al.
Publicado: (2021)

Session B: Androgenetic Alopecia – Part II
Publicado: (2011)

Session C: Androgenetic Alopecia – Part III
Publicado: (2011)

Session A: Androgenetic Alopecia – Part I
Publicado: (2011)

Androgenetic alopecia and risk of coronary artery disease
por: Sharma, Lata, et al.
Publicado: (2013)

Quality of Life Assessment in Patients with Androgenetic Alopecia
por: Gupta, Sanjeev, et al.
Publicado: (2019)

Expert consensus on the management of Androgenetic Alopecia in India
por: Mysore, Venkataram, et al.
Publicado: (2019)

Microbiome in the hair follicle of androgenetic alopecia patients
por: Ho, Bryan Siu-Yin, et al.
Publicado: (2019)

Androgenetic alopecia in COVID-19: Compared to what?
por: Nanes, Benjamin A.
Publicado: (2020)

Platelet-Rich Plasma Therapy for Androgenetic Alopecia
por: Sharma, Vinod K, et al.
Publicado: (2019)

Comorbidities in Androgenetic Alopecia: A Comprehensive Review
por: Chen, Shuang, et al.
Publicado: (2022)

New Target for Minoxidil in the Treatment of Androgenetic Alopecia
por: Shen, Yuqing, et al.
Publicado: (2023)

Cell Therapy for Androgenetic Alopecia: Elixir or Trick?
por: Mao, Yongcui, et al.
Publicado: (2023)

Digital health platforms expand access and improve care for male androgenetic alopecia
por: Young, Peter C., et al.
Publicado: (2022)

Central Centrifugal Cicatricial Alopecia in a Fair Phototype Patient
por: Fernandez-Nieto, Diego, et al.
Publicado: (2019)

Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

The “Starry Night Sky Sign” Using Ultraviolet-Light-Enhanced Trichoscopy: A New Sign That May Predict Efficacy of Treatment in Frontal Fibrosing Alopecia
por: Rodrigues-Barata, Ana Rita, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ggfnstqcik7nmpvomg72oj3kv0